Profil
Oved Amitay formerly worked at The Solve ME, as President, Chief Executive Officer & Director from 2020 to 2023, CeNeS Pharmaceuticals, Inc., as Staff Pharmacologist, Genzyme Corp., as Vice President-Strategic Development from 1998 to 2011, Alnylam Pharmaceuticals, Inc., as Vice President & Head-Commercial from 2012 to 2016, Peptor Ltd, as Staff Pharmacologist, Arrett Neuroscience, Inc., as President & Chief Operating Officer from 2016 to 2018, and Centogene NV, as Chief Business Officer from 2018 to 2020.
Mr. Amitay received his graduate degree from Northeastern University and undergraduate degree from The Hebrew University of Jerusalem.
Ehemalige bekannte Positionen von Oved Amitay
| Unternehmen | Position | Ende |
|---|---|---|
The Solve ME/CFS Initiative
The Solve ME/CFS Initiative Miscellaneous Commercial ServicesCommercial Services Operates as an association to end and cure chronic fatigue syndrome disease | Vorstandsvorsitzender | 16.10.2023 |
| CENTOGENE N.V. | Corporate Officer/Principal | 31.05.2020 |
Arrett Neuroscience, Inc. | Präsident | 01.01.2018 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.06.2016 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01.01.2011 |
Ausbildung von Oved Amitay
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
CeNeS Pharmaceuticals, Inc.
CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceuticals focusing on nerve cell survival & function | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Peptor Ltd
Peptor Ltd Pharmaceuticals: MajorHealth Technology Develops products to treat autoimmune diseases | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Solve ME/CFS Initiative
The Solve ME/CFS Initiative Miscellaneous Commercial ServicesCommercial Services Operates as an association to end and cure chronic fatigue syndrome disease | Commercial Services |
Arrett Neuroscience, Inc. | |
Centogene NV
Centogene NV Medical SpecialtiesHealth Technology Provides genetic diagnostic analyses of rare inherited diseases | Health Technology |
















